- Filed
- Nov 12, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Nov 10, 2021 | 20.16M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 21.3M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 21.03M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 19.63M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 19.58M sh |
| Capex | Q3 2021 · Sep 30, 2021 | $77K |
| Capex | Q3 2021 · Sep 30, 2020 | $340K |
| Operating Cash Flow | Q3 2021 · Sep 30, 2021 | $46.14M |
| Operating Cash Flow | Q3 2021 · Sep 30, 2020 | −$7.35M |
| Long Term Debt | Q3 2021 · Sep 30, 2021 | $4.81M |
| Long Term Debt | Q3 2021 · Dec 31, 2020 | $10.61M |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $117.52M |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $91.44M |
| Stockholders Equity | Q3 2021 · Sep 30, 2021 | $90.77M |
| Stockholders Equity | Q3 2021 · Dec 31, 2020 | $62.94M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $148.53M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $178.92M |
| Total Assets | Q3 2021 · Sep 30, 2021 | $239.79M |
| Total Assets | Q3 2021 · Dec 31, 2020 | $241.33M |
| Total Assets restated | Q3 2021 · Sep 30, 2020 | $212.66M |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | $1.02 |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | $1.26 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.16 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.70 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | $1.10 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | $1.34 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.16 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.70 |
| Net Income | Q3 2021 · Sep 30, 2021 | $21.82M |
| Net Income | Q3 2021 · Sep 30, 2021 | $26.54M |
| Net Income | Q3 2021 · Sep 30, 2020 | −$3.08M |
| Net Income | Q3 2021 · Sep 30, 2020 | −$13.71M |